Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Santhera Pharmaceutical Holding AG

+ Add to Watchlist

SPHDF:US

106.1100 USD 3.2100 3.12%

As of 20:10:03 ET on 05/14/2015.

Snapshot for Santhera Pharmaceutical Holding AG (SPHDF)

Open: 105.3500 Day's Range: 105.3500 - 106.1100 Volume: 308
Previous Close: 102.9000 52wk Range: 28.9000 - 117.2127 1-Yr Rtn: -

Stock Chart for SPHDF

No chart data available.
  • SPHDF:US 106.1100
  • 1D
  • 1M
  • 1Y
102.9000
Interactive SPHDF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SPHDF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2015) -2.3200
Est. PEG Ratio -
Market Cap (M USD) 521.18
Shares Outstanding (M) 4.91
30 Day Average Volume 47
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SPHDF

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for SPHDF

Santhera Pharmaceuticals is a drug discovery and development company. The Company focuses on the discovery, preclinical and clinical development, and commercialization of pharmaceuticals for neuromuscular and metabolic diseases.

Thomas MeierChief Executive OfficerNicholas CoppardSenior VP/Head:Development
Gunther MetzSenior VP:Business DevelopmentGiovanni StropoliChief Commercial Ofcr:Europe & Row
More Company Profile & Key Executives for SPHDF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil